Results 121 to 130 of about 27,042 (199)

Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025. [PDF]

Euro Surveill
Guiomar R, Henriques C, Pereira da Silva S, Gomes L, Dias D, Verdasca N, Portuguese Laboratory Network for the Diagnosis of Influenza and Respiratory Viruses, Nunes B, Rodrigues AP.   +8 more
europepmc   +1 more source

GMT a better bet than SMC?

Reinforced Plastics, 1992
openaire   +1 more source

Surveillance of zoonotic pathogens in cattle and dromedaries sacrificed at the Grand Magal of Touba: a cross-sectional survey. [PDF]

New Microbes New Infect
Ouaddane I, Diouf C, Diatta G, Diarra AZ, Faye M, Sokhna C, Gautret P.   +6 more
europepmc   +1 more source

Phytochemical-Loaded Biodegradable Nanoemulsions for Eradication of Fungal Biofilms. [PDF]

Nanomaterials (Basel)
Hassan MA, Chandrababu H, Park J, Rotello VM.   +3 more
europepmc   +1 more source

Broad and robust T cell immunity compensates the population immune barrier against antibody-escaping Omicron variants. [PDF]

Front Immunol
Guo Y, Guo P, Tian J, Tuluhongtayi Y, Song R, Gao GF, Zhao X, Liu J.   +7 more
europepmc   +1 more source

Modular presses for SMC, BMC and GMT

Reinforced Plastics, 1995
openaire   +1 more source

Investigation of Potential Cross-Protection Conferred by the Seasonal Influenza Vaccine Against Swine Influenza A Viruses of Pandemic Potential. [PDF]

Vaccines (Basel)
Lilley A, Chiapponi C, Prosperi A, Moreno A, Soliani L, Lewis N, Harvey R.   +6 more
europepmc   +1 more source

Effectiveness, immunogenicity and safety of monovalent DS-5670a and bivalent DS-5670a/b SARS-CoV-2 vaccines: results from two randomized, active-comparator, non-inferiority trials. [PDF]

Commun Med (Lond)
Hamada S, Suda M, Ishida K, Furihata K, Sogawa Y, Kumazaki M, Takahashi K, Sakakibara S, Matsunaga S, Jonai N, Nakayama T, Takeshita F.   +11 more
europepmc   +1 more source

A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children. [PDF]

NPJ Vaccines
Hwang KP, Luong QC, Huang YC, Lai CC, Le PH, Thi Tran MT, Tan BF, Chen PY, Yang SC, Liu WT, Thao NTT, Lee P, Lin ST, Liu CC, Chen CC, Yang CF, Huang LM.   +16 more
europepmc   +1 more source

Safety and immunogenicity of 4CMenB and MenACWY-CRM meningococcal vaccines when administered concomitantly in healthy adolescents: A phase 3b, randomized, observer-blind study. [PDF]

Hum Vaccin Immunother
Hoberman A, Atwi J, Silas P, Prato R, Bosis S, Martin JM, Lechevin I, Possidente M, Manzella S, Moraschini L, Lattanzi M, Keshavan P.   +11 more
europepmc   +1 more source